2020
DOI: 10.31146/1682-8658-ecg-179-7-96-101
|View full text |Cite
|
Sign up to set email alerts
|

Features of clinical and metabolic status after bariatric treatment of obesity

Abstract: Purpose of the study. Assessment of metabolic status in patients after bariatric surgery.Materials and methods. 29 patients with I-III degree obesity were examined. Clinical metabolic and micronutrient status was assessed for patients.Results. For patients after bariatric intervention, a more pronounced decrease in muscle mass during weight loss, an increase in the rate of oxidation of carbohydrates, a decrease in the rate of oxidation of fats, a decrease in the concentration level in the blood serum of a numb… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…However, bariatric surgery is still superior to any medical treatment in terms of results 6 . That is why bariatric operations should be performed in such patients 7–11 . It should also be noted that conservative treatment such as GLP-1 RA (glucagon like peptide-1 receptor agonists)–based therapy after surgery was found to be effective to prevent postbariatric weight regain 12 .…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…However, bariatric surgery is still superior to any medical treatment in terms of results 6 . That is why bariatric operations should be performed in such patients 7–11 . It should also be noted that conservative treatment such as GLP-1 RA (glucagon like peptide-1 receptor agonists)–based therapy after surgery was found to be effective to prevent postbariatric weight regain 12 .…”
mentioning
confidence: 99%
“…6 That is why bariatric operations should be performed in such patients. [7][8][9][10][11] It should also be noted that conservative treatment such as GLP-1 RA (glucagon like peptide-1 receptor agonists)-based therapy after surgery was found to be effective to prevent postbariatric weight regain. 12 Similarly, genomics of obesity also suggest that gene therapies and gene editing may have a future role in the management of some patients, 13,14 but more research must be done before it can be made widely available.…”
mentioning
confidence: 99%